The trial included 743 obese participants, aged 18-65 years, with a body mass index (BMI) ranging from 28 to 43 kg/m
Betul Hatipoglu, director of the Center for Diabetes, Obesity and Metabolism at Case Western Reserve University and of the Diabetes and Obesity Center at University Hospitals Cleveland Medical Center, says microdosing Ozempic, Zepbound or another GLP-1 drug might mean: Taking a lower dose than what was prescribed or studied in clinical trials Taking a half-dose every few days instead of a full dose once weekly Taking a full dose less often, such as every 10 or 14 days instead of every seven While these approaches are often grouped together online under the umbrella of "microdosing," they're not exactly the same thing
Patients receive shipments directly without insurance requirements or membership fees, making treatment accessible regardless of provincial health coverage policies
These drugs mimic the GLP-1 hormone, which your body naturally releases after eating
PPC-157 ist ein Nahrungsergnzungsmittel mit zugelassenen Inhaltsstoffen und entspricht den geltenden lebensmittelrechtlichen Vorgaben
